|
2024
|
Invention
|
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics.
This i... |
|
2023
|
Invention
|
Microbiome protection from oral antibiotics.
This invention provides, in part, various compositi... |
|
|
Invention
|
Safe and effective beta-lactamase dosing for microbiome protection.
The present invention relate... |
|
|
Invention
|
Treatment or prevention of gastrointestinal immunotherapy side effects. The present disclosure re... |
|
|
G/S
|
Pharmaceutical preparations for the treatment, prevention and alleviation of gastrointestinal dis... |
|
|
Invention
|
Methods and compositions for attenuating antibiotic resistance.
The present invention provides, ... |
|
|
Invention
|
Ulcerative colitis treatments in selected patients. The present disclosure relates, inter alia, t... |
|
|
Invention
|
Modified beta-lactamases and methods and uses related thereto.
The present invention relates to ... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of radiation disorders.
The present invention relates ... |
|
|
Invention
|
Intestinal alkaline phosphatase formulations.
The present invention provides for a formulation c... |
|
|
Invention
|
Beta-lactamases with improved properties for therapy.
This invention relates to, in part, compos... |
|
|
Invention
|
Method and compositions for inhibiting or preventing adverse effects of oral antibiotics. This in... |
|
2022
|
Invention
|
E. coli-based production of beta-lactamase. E. coli) cells. High yield production of beta-lactama... |
|
|
Invention
|
Microbiome protection from oral antibiotics. This invention provides, in part, various compositio... |
|
|
Invention
|
Alkaline phosphatase-based treatments of celiac disease.
The present disclosure relates, inter a... |
|
|
Invention
|
Alkaline phosphatase-based treatments of celiac disease. The present disclosure relates, inter al... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of neurodevelopmental disorders.
The present invention... |
|
|
Invention
|
Safe and effective beta-lactamase dosing for microbiome protection. The present invention relates... |
|
2021
|
Invention
|
Beta-lactamases with improved properties for therapy. C. difficile infection (CDI). |
|
|
Invention
|
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome.
This in... |
|
|
Invention
|
Alkaline phosphatase formulations. The present invention provides, in part, formulations comprisi... |
|
2020
|
Invention
|
Beta-lactamase formulations and uses thereof. The present invention provides, in part, formulatio... |
|
|
Invention
|
Intestinal alkaline phosphatase-based treatments of metabolic disorders.
The present invention r... |
|
|
Invention
|
Intestinal alkaline phosphatase-based treatments of metabolic disorders. The present invention re... |
|
|
Invention
|
Alkaline phosphatase formulations and uses thereof.
The present invention provides, in part, for... |
|
|
Invention
|
Alkaline phosphatase formulations and uses thereof. The present invention provides, in part, form... |
|
|
Invention
|
Alkaline phosphate-based oncology treatments.
The present invention relates to methods and compo... |
|
|
Invention
|
Alkaline phosphate-based oncology treatments. The present invention relates to methods and compos... |
|
|
Invention
|
Beta-lactamase compositions for treatment of graft versus host disease. The present invention rel... |
|
2019
|
Invention
|
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome. This inv... |
|
|
Invention
|
Methods of making alkaline phosphatase agents.
The present invention relates to, inter alia, com... |
|
|
Invention
|
Methods of making alkaline phosphatase agents. The present invention relates to, inter alia, comp... |
|
|
Invention
|
Intestinal alkaline phosphatase formulations. The present invention provides for a formulation co... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of radiation disorders. The present invention relates t... |
|
|
Invention
|
Modified beta-lactamases and methods and uses related thereto. The present invention relates to p... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of neurodevelopmental disorders. Compositions and metho... |
|
|
Invention
|
Alkaline phosphatase agents for treatment of neurodevelopmental disorders. The present invention ... |
